GSPQX
Price
$20.44
Change
+$0.07 (+0.34%)
Updated
Aug 21 closing price
Net Assets
3.94B
HADUX
Price
$85.13
Change
+$0.40 (+0.47%)
Updated
Aug 21 closing price
Net Assets
178.23M
Interact to see
Advertisement

GSPQX vs HADUX

GSPQX vs HADUX Comparison Chart in %
View a ticker or compare two or three
VS
GSPQX vs. HADUX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSPQX is a StrongBuy and HADUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GSPQX has more cash in the bank: 3.94B vs. HADUX (178M). HADUX pays higher dividends than GSPQX: HADUX (7.22) vs GSPQX (0.06). GSPQX was incepted earlier than HADUX: GSPQX (21 years) vs HADUX (9 years). GSPQX (1.86) is less costly to investors than HADUX (1.24). GSPQX is a more actively managed with annual turnover of: 29.00 vs. HADUX (10.00). GSPQX has a lower initial minimum investment than HADUX: GSPQX (1000) vs HADUX (2500). HADUX annual gain was more profitable for investors over the last year : 21.40 vs. GSPQX (13.89). HADUX return over 5 years is better than : 63.45 vs. GSPQX (27.70).
GSPQXHADUXGSPQX / HADUX
Total Expense Ratio1.751.24141%
Annual Report Gross Expense Ratio1.861.24150%
Fund Existence21 years9 years-
Gain YTD12.65112.631100%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets3.94B178M2,212%
Annual Yield % from dividends0.067.221%
Returns for 1 year13.8921.4065%
Returns for 3 years39.7771.6056%
Returns for 5 years27.7063.4544%
Returns for 10 years75.02N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USIO2.810.15
+5.64%
Usio
PRLD6.630.13
+2.00%
Prelude Therapeutics
PMAX1.260.02
+1.61%
Powell Max Limited
BWXT156.780.34
+0.22%
BWX Technologies
SUPN45.85-1.60
-3.37%
Supernus Pharmaceuticals